Targeting the alternative NF-κB pathway in pancreatic cancer

A new direction for therapy?

Research output: Contribution to journalArticle

14 Citations (Scopus)
Original languageEnglish (US)
Pages (from-to)501-504
Number of pages4
JournalExpert Review of Anticancer Therapy
Volume13
Issue number5
DOIs
StatePublished - May 2013

Fingerprint

TNF Receptor-Associated Factor 2
Molecular Targeted Therapy
NF-kappa B
Drug Design
Delayed Diagnosis
Pancreatic Neoplasms
Antineoplastic Agents
Signal Transduction
Therapeutics
Direction compound

Keywords

  • alternative
  • MAP3K14
  • NF-κB
  • NIK
  • noncanonical
  • pancreatic cancer
  • therapy
  • TRAF2

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Oncology

Cite this

Targeting the alternative NF-κB pathway in pancreatic cancer : A new direction for therapy? / Storz, Peter.

In: Expert Review of Anticancer Therapy, Vol. 13, No. 5, 05.2013, p. 501-504.

Research output: Contribution to journalArticle

@article{d78dfcbf204b4962b4641f23f78a845b,
title = "Targeting the alternative NF-κB pathway in pancreatic cancer: A new direction for therapy?",
keywords = "alternative, MAP3K14, NF-κB, NIK, noncanonical, pancreatic cancer, therapy, TRAF2",
author = "Peter Storz",
year = "2013",
month = "5",
doi = "10.1586/era.13.28",
language = "English (US)",
volume = "13",
pages = "501--504",
journal = "Expert Review of Anticancer Therapy",
issn = "1473-7140",
publisher = "Expert Reviews Ltd.",
number = "5",

}

TY - JOUR

T1 - Targeting the alternative NF-κB pathway in pancreatic cancer

T2 - A new direction for therapy?

AU - Storz, Peter

PY - 2013/5

Y1 - 2013/5

KW - alternative

KW - MAP3K14

KW - NF-κB

KW - NIK

KW - noncanonical

KW - pancreatic cancer

KW - therapy

KW - TRAF2

UR - http://www.scopus.com/inward/record.url?scp=84876824209&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84876824209&partnerID=8YFLogxK

U2 - 10.1586/era.13.28

DO - 10.1586/era.13.28

M3 - Article

VL - 13

SP - 501

EP - 504

JO - Expert Review of Anticancer Therapy

JF - Expert Review of Anticancer Therapy

SN - 1473-7140

IS - 5

ER -